-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
-
Summary
-
Lomond Therapeutics Holdings, Inc. annual/quarterly Net Cash Provided by (Used in) Operating Activities history and growth rate from 2022 to 2024.
- Lomond Therapeutics Holdings, Inc. Net Cash Provided by (Used in) Operating Activities for the quarter ending March 31, 2024 was -$591.000, a 94.4% increase year-over-year.
- Lomond Therapeutics Holdings, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2024 was -$12K, a 43.1% decline from 2023.
- Lomond Therapeutics Holdings, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2023 was -$8.41K, a 81.3% increase from 2022.
Net Cash Provided by (Used in) Operating Activities, Annual (USD)
Net Cash Provided by (Used in) Operating Activities, YoY Annual Growth (%)